<DOC>
	<DOCNO>NCT00042926</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure detect cancer cell sentinel lymph node may help plan effective cancer treatment . PURPOSE : Diagnostic trial study effectiveness lymph node mapping sentinel lymph node lymphadenectomy patient undergo surgery remove early-stage cancer mouth .</brief_summary>
	<brief_title>Diagnostic Trial Patients Who Are Undergoing Surgery Early Stage Mouth Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether negative hematoxylin eosin find lymphatic mapping sentinel node lymphadenectomy procedure accurately predict negativity cervical lymph node patient stage I II squamous cell carcinoma oral cavity . - Determine extent pattern disease spread nodal bed patient . - Obtain data use immunohistochemistry ass node patient .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>1 . Patient must &gt; 18 year age . 2 . Patient must ECOG/Zubrod performance status &lt; 2 . 3 . Patient must histologically confirm primary T1 T2 invasive OCSCCA &gt; 6mm &lt; 4 cm size . The primary tumor must amenable curative resection must diagnose within 42 day prior surgery . 4 . Patient must clinically stage N0 confirm negative imaging study employ contrastenhanced CT scan ( MRI gadolinium patient iodine allergy ) . Lymph node consider positive : Greater 1.5 cm size level I II . Greater 1 cm size level III , IV , V VI . If lymph node exhibit central necrosis , irregular enhancement poorly define irregular capsular border . Groups three asymmetrically locate LNs , minimal axial diameter 8 mm , suspect tumor drainage area present . NOTE : All CT scan must read neuroradiologist . 5 . Patient must medically fit neck dissection . 6 . Patient patient 's legally acceptable representative must provide sign dated write informed consent prior registration studyrelated procedure . 7 . Female patient childbearing potential must negative serum pregnancy test within 30 daysprior registration . 8 . If patient survivor prior cancer , ALL follow criterion meet : 1 . Patient undergone potentially curative therapy prior malignancy , 2 . No evidence prior malignancy least 5 year evidence recurrence ( except effectively treat basal cell squamous carcinoma skin , carcinoma insitu cervix effectively treat surgery alone , lobular carcinoma insitu ipsilateral contralateral breast treat surgery alone ) , 3 . Patient deem treat physician low risk recurrence prior malignancy . 1 . Patient receive prior treatment cervical lymph node , include surgery radiation therapy . 2 . Patient experience prior extensive trauma anterior cervical region neck . 3 . Patient lesion cross vermilion border involve lip skin . 4 . Patient previous tumor resection involve neck . 5 . Patient injection radioactive material previous scan within 48 hour radiolymphoscintigraphy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
</DOC>